Background
No data on long-term outcomes of survivors of 2009 influenza A(H1N1) (A[H1N1])-associated
ARDS are available. The objective of this study was to compare the 1-year outcomes
of survivors of A(H1N1)-associated ARDS, according to use or no use of extracorporeal
lung assist (ECLA), using its need as an ARDS severity surrogate.
Methods
Survivors of ARDS (12 with ECLA use vs 25 without, corresponding to 75% and 54% of
the eligible patients for each group, respectively) selected from the Réseau Européen
de Ventilation Artificielle (REVA) registry had previously been healthy, with only
pregnancy and/or moderate obesity (BMI ≤ 35 kg/m2) as known risk factors for A(H1N1) infection. Lung function and morphology, health-related
quality of life (HRQoL), and psychologic impairment were evaluated.
Results
At 1 year post-ICU discharge for the ECLA and no-ECLA groups, respectively, 50% and
40% reported significant exertion dyspnea, 83% and 64% had returned to work, and 75%
and 64% had decreased diffusion capacity across the blood-gas barrier, despite their
near-normal and similar lung function test results. For both groups, exercise test
results showed diminished but comparable exercise capacities, with similar alveolar-arterial
oxygen gradients at peak exercise, and CT scans showed minor abnormal findings. HRQoL
assessed by the 36-Item Short-Form Health Survey was poorer for both groups than for
a sex- and age-matched general population group, but without between-group differences.
ECLA and no-ECLA group patients, respectively, had symptoms of anxiety (50% and 56%)
and depression (28% and 28%) and were at risk for posttraumatic stress disorder (41%
and 44%).
Conclusions
One year post-ICU discharge, a majority of survivors of A(H1N1)-associated ARDS had
minor lung disabilities with diminished diffusion capacities across the blood-gas
barrier, and most had psychologic impairment and poorer HRQoL than a sex- and age-matched
general population group. ECLA and no-ECLA group patients had comparable outcomes.
Trial registry
To read this article in full you will need to make a payment
Subscribe to CHEST
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Sequelae of the adult respiratory distress syndrome.Thorax. 1994; 49: 8-13
- Health-related quality of life and posttraumatic stress disorder in survivors of the acute respiratory distress syndrome.Crit Care Med. 1998; 26: 651-659
- One-year outcomes in survivors of the acute respiratory distress syndrome.N Engl J Med. 2003; 348: 683-693
- Morbidity, mortality, and quality-of-life outcomes of patients requiring >or=14 days of mechanical ventilation.Crit Care Med. 2003; 31: 1373-1381
- Two-year outcomes, health care use, and costs of survivors of acute respiratory distress syndrome.Am J Respir Crit Care Med. 2006; 174: 538-544
- Self-reported symptoms of depression and memory dysfunction in survivors of ARDS.Chest. 2009; 135: 678-687
- Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.N Engl J Med. 2010; 362: 1708-1719
- Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome.JAMA. 2009; 302: 1888-1895
- ECMO in ARDS: a long-term follow-up study regarding pulmonary morphology and function and health-related quality of life.Acta Anaesthesiol Scand. 2009; 53: 489-495
- Adult intensive-care patients with 2009 pandemic influenza A(H1N1) infection.Epidemiol Infect. 2010; 139: 1202-1209
- Acute respiratory distress syndrome due to influenza A (H1N1)2009: recommendations for respiratory management.(Accessed July 11, 2012)
- Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.N Engl J Med. 2000; 342: 1301-1308
- The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.Am J Respir Crit Care Med. 1994; 149: 818-824
- Gram-negative bacteremia.Arch Intern Med. 1962; 110: 847-855
- The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.Intensive Care Med. 1996; 22: 707-710
- SAPS 3—from evaluation of the patient to evaluation of the intensive care unit. Part 2: development of a prognostic model for hospital mortality at ICU admission.Intensive Care Med. 2005; 31: 1345-1355
- The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.Med Care. 1994; 32: 40-66
- The hospital anxiety and depression scale.Acta Psychiatr Scand. 1983; 67: 361-370
- Sensitivity and specificity of a screening test to document traumatic experiences and to diagnose post-traumatic stress disorder in ARDS patients after intensive care treatment.Intensive Care Med. 1999; 25: 697-704
- Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease.Am Rev Respir Dis. 1987; 135: 1229-1233
- Albumin, transferrin and the thyroxine-binding prealbumin/retinol-binding protein (TBPA-RBP) complex in assessment of malnutrition.Clin Chim Acta. 1975; 63: 61-67
- Prealbumin in nutrition evaluation.Nutrition. 1996; 12: 255-259
- Serum prealbumin: is it a marker of nutritional status or of risk of malnutrition?.Clin Chem. 2006; 52: 2177-2179
- Predicted values for clinical exercise testing.Am Rev Respir Dis. 1984; 129: S49-S55
- Functional disability 5 years after acute respiratory distress syndrome.N Engl J Med. 2011; 364: 1293-1304
- Recovery of function in survivors of the acute respiratory distress syndrome.Am J Respir Crit Care Med. 1994; 150: 90-94
- Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients.JAMA. 1999; 281: 354-360
- Quality-adjusted survival in the first year after the acute respiratory distress syndrome.Am J Respir Crit Care Med. 2001; 163: 1389-1394
- Two-year cognitive, emotional, and quality-of-life outcomes in acute respiratory distress syndrome.Am J Respir Crit Care Med. 2005; 171: 340-347
Bienvenu OJ, Colantuoni E, Mendez-Tellez PA, et al. Depressive symptoms and impaired physical function after acute lung injury: a 2-year longitudinal study [published online ahead of print December 8, 2011]. Am J Respir Crit Care Med. doi:10.1164/rccm.201103-0503OC.
- Quality of life after acute respiratory distress syndrome: a meta-analysis.Intensive Care Med. 2006; 32: 1115-1124
- Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.Lancet. 2009; 374: 1351-1363
- Paresis acquired in the intensive care unit: a prospective multicenter study.JAMA. 2002; 288: 2859-2867
- Measurement of muscle strength in the intensive care unit.Crit Care Med. 2009; 37: S321-S330
- Neuromuscular blockers in early acute respiratory distress syndrome.N Engl J Med. 2010; 363: 1107-1116
Article Info
Publication History
Accepted:
January 10,
2012
Received:
August 30,
2011
Footnotes
Members of the REVA Study Group are listed in e-Appendix 1.
Funding/Support: This study was funded by a grant from the INSERM-Institut de Microbiologie et Maladies Infectieuses, France, and French Ministry of Health.
Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.
Identification
Copyright
© 2012 The American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- The Homogeneous and Robust Clinical Phenotype of Severe Lung InjuryCHESTVol. 142Issue 3
- PreviewAcute-onset severe lung injury, regardless of etiology or associated risk factors, is universally recognized in terms of its sameness. Patients with this condition share many similarities, including younger age, few comorbidities, recovery of lung function in those without preexisting lung disease, ICU-acquired weakness (ICUAW), and neuropsychologic dysfunction. These patients also share resilience and recovery from a profound, multisystem, and exuberant inflammatory response. These outcomes are robust over time and across different countries and investigators.
- Full-Text
- Preview
